EPAS1 and metabolic dysfunction-associated steatotic liver disease: In particular, one should emphasize that in the liver and in the scenario of a metabolic disease (NAFLD essentially develops in obese and/or type 2 diabetic patients), HIF-2α has a critical role in the control of glucose and fatty acid metabolism [123].